Olfr50 Inhibitors
Olfr50, an integral component of the olfactory receptor family, stands as a key player in the intricate orchestration of olfactory perception. Operating within the nasal environment, Olfr50, like its counterparts, fulfills the role of a G-protein-coupled receptor (GPCR). This particular GPCR, arising from a single coding-exon gene, plays a vital role in detecting and transducing signals emanating from odorant molecules. Structurally, Olfr50 shares a commonality with neurotransmitter and hormone receptors, characterized by a 7-transmembrane domain architecture. As a member of the largest gene family in the genome, olfactory receptors, Olfr50's function lies in the recognition and G protein-mediated transduction of odorant signals. This family's diversity is further emphasized by the independent nomenclature assigned to olfactory receptor genes and proteins, underlining the unique nature of olfactory signaling within this organism.
The inhibition of Olfr50 involves a sophisticated interplay of chemical agents that can act either directly or indirectly to modulate its function. Direct inhibitors, such as Gβγ inhibitors or MEK inhibitors, exert their impact by specifically targeting components of signaling pathways associated with Olfr50. For instance, Gallein disrupts G-protein signaling, directly inhibiting Olfr50 and potentially altering the neuronal response involved in olfactory signal transduction. On the other hand, indirect inhibitors operate by influencing cellular processes related to Olfr50 function. Calcium channel blockers or PI3K inhibitors may impact Olfr50 by modulating intracellular calcium levels or disrupting the PI3K-Akt pathway, respectively. These alterations in cellular processes ultimately impact G-protein-mediated transduction, thereby influencing the neuronal response to odorant signals and potentially altering the perception of odors in the olfactory system. The intricate web of signaling pathways involved in olfactory signal transduction is unveiled through the diverse mechanisms of inhibition, shedding light on the regulatory networks governing Olfr50 within the molecular landscape of smell perception.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Gallein | 2103-64-2 | sc-202631 | 50 mg | $85.00 | 20 | |
Gallein, a Gβγ inhibitor, directly inhibits Olfr50 by disrupting G-protein signaling. Its interference with G-protein-mediated transduction could impact the neuronal response involved in olfactory signal transduction, affecting the perception of smell. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, a MEK inhibitor, directly inhibits the MAPK pathway. By disrupting this pathway, it may influence downstream elements affecting Olfr50, potentially altering G-protein-coupled receptor signaling and impacting olfactory perception. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
PTX (Pertussis toxin) inhibits G-protein signaling. Olfr50, being a GPCR, may be indirectly affected, as pertussis toxin disrupts G-protein-mediated transduction. This interference could alter the neuronal response to odorant signals in the olfactory system. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, may indirectly influence Olfr50 by inhibiting the PI3K-Akt pathway. Modulating this pathway could impact cellular processes associated with olfactory signal transduction, potentially affecting the perception of odors. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil, a calcium channel blocker, could indirectly impact Olfr50 by modulating intracellular calcium levels. Changes in calcium signaling may affect G-protein-mediated transduction and alter the neuronal response to odorant molecules, impacting olfactory perception. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, directly targets the MAPK pathway. Inhibition of this pathway may affect downstream elements involved in olfactory signal transduction, potentially influencing Olfr50 and altering the perception of odors in the olfactory system. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3K inhibitor, could indirectly influence Olfr50 by disrupting the PI3K-Akt pathway. Modulating this pathway may impact cellular processes associated with olfactory signal transduction, potentially affecting the perception of odors. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin, a SERCA inhibitor, may indirectly inhibit Olfr50 by disrupting calcium homeostasis. Changes in intracellular calcium levels could influence G-protein-mediated transduction, altering the neuronal response to odorant signals and impacting olfactory perception. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93, a CaMKII inhibitor, may indirectly affect Olfr50 by modulating calcium/calmodulin-dependent signaling pathways. Disruption of these pathways could impact G-protein-coupled receptor function, potentially altering the neuronal response to odorant signals in the olfactory system. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
GF109203X, a PKC inhibitor, may indirectly influence Olfr50 by modulating PKC-mediated signaling pathways. Disruption of these pathways could impact G-protein-coupled receptor function, potentially altering the neuronal response to odorant signals in the olfactory system. | ||||||